Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

Market Cap	9.48B
Revenue (ttm)	3.55B
Net Income (ttm)	414.65M
Shares Out	454.07M
EPS (ttm)	0.91
PE Ratio	22.94
Forward PE	19.25
Dividend	0.30 (1.44%)
Ex-Dividend Date	May 21, 2025

Volume	4,840,200
Average Volume	8,292,951
Open	22.23
Previous Close	20.90
Day's Range	20.74 - 22.23
52-Week Range	14.13 - 28.90
Beta	0.22
RSI	40.05
Earnings Date	Oct 24, 2025

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company offers anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poultry...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,900
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300119

Financial Performance

In 2024, SHE:300119's revenue was 3.07 billion, an increase of 13.32% compared to the previous year's 2.71 billion. Earnings were 300.72 million, a decrease of -33.70%.